Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/09/2003 | US20030008368 Serine O-acetytransferase |
01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
01/09/2003 | US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |
01/09/2003 | US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/09/2003 | US20030008351 Nucleotide sequences coding polypeptide for use in the treatment of heart defects |
01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
01/09/2003 | US20030008345 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
01/09/2003 | US20030008340 Metabolic biosensor and uses thereof |
01/09/2003 | US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer |
01/09/2003 | US20030008321 Antibody for use as tool in immunoassay |
01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/09/2003 | US20030008291 Protein for use in diagnosis and treatment of cancer |
01/09/2003 | US20030008288 Detection and treatment of polycystic kidney disease |
01/09/2003 | US20030008284 Polynucleotides related to colon cancer |
01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
01/09/2003 | US20030007955 Enclosures housing cell-coated supports for treating tumors |
01/09/2003 | US20030007952 Polypeptides |
01/09/2003 | CA2650762A1 Capsules containing vital cells or tissues |
01/09/2003 | CA2486789A1 Compositions and methods for inferring a response to a statin |
01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
01/09/2003 | CA2452082A1 Extracellular messengers |
01/09/2003 | CA2452029A1 A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases |
01/09/2003 | CA2451580A1 Artificial synapse chip interface for electronic prosthetic retina |
01/09/2003 | CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
01/09/2003 | CA2450710A1 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
01/09/2003 | CA2449105A1 Novel technology for genetic mapping |
01/09/2003 | CA2446580A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
01/08/2003 | EP1273662A2 Reversible nuclear genetic system for male sterility in transgenic plants |
01/08/2003 | EP1273312A2 Implant for cartilage tissue regeneration |
01/08/2003 | EP1273304A2 Use of interleukin-15 |
01/08/2003 | EP1272846A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
01/08/2003 | EP1272677A1 Suppressor of hiv replication and transcription |
01/08/2003 | EP1272668A2 Methods, compositions and kits for the detection and monitoring of breast cancer |
01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
01/08/2003 | EP1272656A1 Human serine racemase |
01/08/2003 | EP1272647A1 Multivalent antibodies and uses therefor |
01/08/2003 | EP1272642A2 Coffee mannanase |
01/08/2003 | EP1272641A2 Serine-threonine kinase |
01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
01/08/2003 | EP1272630A2 Methods and compositions for rna interference |
01/08/2003 | EP1272629A1 Genetic silencing |
01/08/2003 | EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast |
01/08/2003 | EP1272621A1 Plant anthocyanidin rutinoside aromatic acyl transferases |
01/08/2003 | EP1272619A2 Human ovarian mesothelial cells and methods of isolation and uses thereof |
01/08/2003 | EP1272618A2 Synchronization of the cytoplasmatic and nuclear maturation of oocytes in vitro |
01/08/2003 | EP1272617A2 Prostate cell lines and their use |
01/08/2003 | EP1272616A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
01/08/2003 | EP1272615A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
01/08/2003 | EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
01/08/2003 | EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof |
01/08/2003 | EP1272529A1 Macroporous chitosan beads and preparation method thereof |
01/08/2003 | EP1272527A2 Anti-d monoclonal antibodies |
01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
01/08/2003 | EP1272513A2 Neurogenic compositions and methods |
01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
01/08/2003 | EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i |
01/08/2003 | EP1272502A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
01/08/2003 | EP1272203A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
01/08/2003 | EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
01/08/2003 | EP1005358B1 Use of a neurturin protein product for preventing and treating hearing loss |
01/08/2003 | EP0996727B1 Gene conferring obese phenotype |
01/08/2003 | EP0974111B1 Apparatus and method for automated protein design |
01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
01/08/2003 | EP0751996B1 Luciferases |
01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
01/08/2003 | CN1390258A Factor IX/factor IXa antibodies and antibody derivatives |
01/08/2003 | CN1390257A Transfer compounds, the production and the use thereof |
01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
01/08/2003 | CN1390141A Nucleic acid-containing complex |
01/08/2003 | CN1390138A Novel use of antibodies as vaccines |
01/08/2003 | CN1389566A Nerve stem cell culture medium and its prepn. |
01/08/2003 | CN1389565A Culture process of human nerve stem cell |
01/08/2003 | CN1389184A Biotechnological body bone tissue rack and its making process and use |
01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
01/07/2003 | US6504082 Ecdysone receptors and methods for their use |
01/07/2003 | US6504007 GDNF receptor |
01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
01/07/2003 | US6503753 Method for the development of an HIV vaccine |
01/07/2003 | US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster |
01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
01/07/2003 | US6503717 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells |
01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |